Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation

References

• Snowden JA, Sánchez-Ortega I, Corbacioglu S. et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57(8):1217–1239. doi:10.1038/s41409-022-01691-w
   PubMed Web of Science ®Google Scholar
• Khaddour K, Hana CK, Mewawalla P. Hematopoietic stem cell transplantation. StatPearls [Internet]. StatPearls Publishing. Treasure Island (FL), USA: StatPearls Publishing. 2022. 1–25. PMID: 30725636. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536951/. Accessed May 28 2024.
   Google Scholar
• Christopeit M, Schmidt-Hieber M, Sprute R, et al. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the infectious diseases working party (AGIHO) of the German society of hematology and medical oncology (DGHO). Ann Hematol. 2021;100(2):321–336. doi:10.1007/s00277-020-04297-8
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E. Infections after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Infect Hematol. 2014;27:49–61.
   Google Scholar
• Rojas-Rechy MH, Gaytán-Morales F, Sánchez-Ponce Y, et al. Herpesvirus screening in childhood hematopoietic transplant reveals high systemic inflammation in episodes of multiple viral detection and an EBV association with elevated IL-1β, IL-8 and graft-versus-host disease. Microorganisms. 2022;10(8):1685. doi:10.3390/microorganisms10081685
   PubMed Web of Science ®Google Scholar
• Kim YJ, Waghmare A, Xie H, et al. Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes. Blood Adv. 2022;6(18):5307–5316. doi:10.1182/bloodadvances.2021004915
   PubMed Web of Science ®Google Scholar
• Gentile G, Andreoni M, Antonelli G, et al. Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review. Clin Microbiol Infect. 2017;23(12):916–923. doi:10.1016/j.cmi.2017.06.024
   PubMed Web of Science ®Google Scholar
• Oliver NT, Nieto YL, Blechacz B, et al. Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation. Bone Marrow Transplant. 2017;52(1):138–140. doi:10.1038/bmt.2016.196
   PubMed Web of Science ®Google Scholar
• Štajner T, Vujić D, Srbljanović J, et al. Risk of reactivated toxoplasmosis in haematopoietic stem cell transplant recipients: a prospective cohort study in a setting withholding prophylaxis. Clin Microbiol Infect. 2022;28(5):733.e1–733.e5. doi:10.1016/j.cmi.2021.09.012
   PubMed Web of Science ®Google Scholar
• Sahitya DSK, Jandiyal A, Jain A, et al. Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation. Ther Adv Infect Dis. 2021;27(8):20499361211053480. doi:10.1177/20499361211053480
   Google Scholar
• Yan CH, Wang Y, Mo XD, et al. Incidence, risk factors, microbiology and outcomes of pre-engraftment bloodstream infection after haploidentical hematopoietic stem cell transplantation and comparison with HLA-identical sibling transplantation. Clin Infect Dis. 2018;67(2):S162–S173. doi:10.1093/cid/ciy658.
   PubMedGoogle Scholar
• Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis. 2015;7(1):e2015045. doi:10.4084/mjhid.2015.045
   PubMedGoogle Scholar
• Moghnieh R, Tamim H, Abyad A, et al. Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon. Infection. 2020;48(3):385–401. doi:10.1007/s15010-020-01407-6.
   PubMed Web of Science ®Google Scholar
• Esquirol A, Pascual MJ, Kwon M, et al. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2021;56(10):2432–2444. doi:10.1038/s41409-021-01328-4
   PubMed Web of Science ®Google Scholar
• Girmenia C, Bertaina A, Piciocchi A, et al. Incidence, risk factors and outcome of pre-engraftment gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey. Clin Infect Dis. 2017;65(11):1884–1896. doi:10.1093/cid/cix690.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhao Y, Luo Y, et al. Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell transplantation recipients. Infect Drug Resist. 2022;15:6893–6905. doi:10.2147/idr.s392804
   PubMed Web of Science ®Google Scholar
• Mendes ET, Salomão MC, Tomichi LM, et al. Effectiveness of surveillance cultures for high priority multidrug-resistant bacteria in hematopoietic stem cell transplant units. Rev Inst Med Trop Sao Paulo. 2021;63:e77. 10.1590/s1678-9946202163077
   PubMed Web of Science ®Google Scholar
• Kamel NA, Elsayed KM, Awad MF, et al. Multimodal interventions to prevent and control carbapenem-resistant Enterobacteriaceae and extended-spectrum β-lactamase producer-associated infections at a tertiary care hospital in Egypt. Antibiotics. 2021;10(5):509. doi:10.3390/antibiotics10050509
   Google Scholar
• CLSI: Performance standards for antimicrobial susceptibility testing M 100 In: 31st Edition. vol. 31; 2021. Available from: https://clsi.org/standards/products/microbiology/documents/m100/. Accessed February 22, 2023.
   Google Scholar
• CDC. Centers for disease control and prevention: guidance for antigen testing for SARS-CoV-2 for healthcare providers. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html>. Accessed February 5, 2024.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x.
   PubMed Web of Science ®Google Scholar
• Carreira AS, Salas MQ, Remberger M, et al. Bloodstream infections and outcomes following allogeneic hematopoietic cell transplantation: a single-center study. Transplant Cell Ther. 2022;28(1):50.e1–50.e8. doi:10.1016/j.jtct.2021.10.008
   PubMedGoogle Scholar
• Satlin MJ, Weissman SJ, Carpenter PA, et al. American society of transplantation and cellular therapy series, 1: enterobacterales infection prevention and management after hematopoietic cell transplantation. Transplant Cell Ther. 2021;27(2):108–114. doi:10.1016/j.jtct.2020.10.001
   PubMedGoogle Scholar
• Reed DR, Petroni GR, West M, et al. Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2023;16(1):61–69. doi:10.1016/j.hemonc.2021.05.001
   PubMedGoogle Scholar
• Akhmedov M. Infectious complications in allogeneic hematopoietic cell transplant recipients: review of transplant-related risk factors and current state of prophylaxis. Clin Transplant. 2021;35(2):e14172. doi:10.1111/ctr.14172
   PubMed Web of Science ®Google Scholar
• Rahi MS, Jindal V, Pednekar P, et al. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Ther Adv Infect Dis. 2021;8:20499361211039050. doi:10.1177/20499361211039050
   Web of Science ®Google Scholar
• Wang J, Zhou M, Xu JY, et al. Comparison of antifungal prophylaxis drugs in patients with hematological disease or undergoing hematopoietic stem cell transplantation: a systematic review and network meta-analysis. JAMA Network Open. 2020;3(10):e2017652. doi:10.1001/jamanetworkopen.2020.17652.
   PubMed Web of Science ®Google Scholar
• Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356(4):335–347. doi:10.1056/nejmoa061098.
   PubMed Web of Science ®Google Scholar
• Rauwolf KK, Floeth M, Kerl K, et al. Toxoplasmosis after allogeneic haematopoietic cell transplantation-disease burden and approaches to diagnosis, prevention and management in adults and children. Clin Microbiol Infect. 2021;27(3):378–388. doi:10.1016/j.cmi.2020.10.009.
   PubMed Web of Science ®Google Scholar
• Nellore A, Lee RA. Multidrug-Resistant Organisms: pre-transplant Evaluation and Management. In: Morris MI, Kotton CN, Wolfe CR, editors. Emerging Transplant Infections. USA, Cham: Springer; 2021:287–312. doi:10.1007/978-3-030-25869-6_8
   Google Scholar
• Grmek Kosnik I, Storman A, Petrovic Z, et al. The evaluation of MRSA surveillance cultures by the number and combinations of anatomical sites. Zdr Varst. 2016;56(1):24–30. doi:10.1515/sjph-2017-0004.
   PubMed Web of Science ®Google Scholar
• Al Musawi S, Alkhaleefa Q, Alnassri S, et al. Predictive role of targeted, active surveillance cultures for detection of methicillin-resistant. Staphylococcus aureus Infect Drug Resist. 2021;14:4757–4764. doi:10.2147/idr.s340871
   PubMed Web of Science ®Google Scholar
• Öksüz L, Hindilerden İY, Erciyestepe M, et al. The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study. New Microbiol. 2022;45(1):40–50. PMID: 35403846.
   PubMed Web of Science ®Google Scholar
• Torres I T, Huntley D, Tormo M, et al. Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients. BMC Infect Dis. 2022;22(1):172. doi:10.1186/s12879-022-07154-3
   PubMed Web of Science ®Google Scholar
• Pereira MR, Pouch SM, Scully B. Infections in allogeneic stem cell transplantation. Princ Pract Transplant Infect Dis. 2018;8:209–226.
   Google Scholar
• Fiorenza S, Turtle CJ. Associations between the gut microbiota, immune reconstitution, and outcomes of allogeneic hematopoietic stem cell transplantation. Immunometabolism. 2021;3(1):e210004. doi:10.20900/immunometab20210004
   PubMedGoogle Scholar
• Gea-Banacloche J. Risks and epidemiology of infections after hematopoietic stem cell transplantation. Transplant Infections: Fourth Edition. editors. Ljungman P, Snydman D, Boeckh M. Cham. Springer International Publishing, USA. 2016. 81–99. 10.1007/978-3-319-28797-3_6
   Google Scholar
• George B, Bhattacharya S. Infections in hematopoietic stem cell transplantation (HSCT) Patients. In: Chandy M, Radhakrishnan VS, Sukumaran RK, editors. Contemp Bone Marrow Transplant. Organ and Tissue Transplantation. Cham: Springer USA; 2021:545–560. doi:10.1007/978-3-030-36358-1_7
   Google Scholar
• Füller MA, Kampmeier S, Wübbolding AM, et al. Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center. Support Care Cancer. 2022;30(9):7231–7239. doi:10.1007/s00520-022-07140-0
   PubMed Web of Science ®Google Scholar
• Alexander T, Snowden JA, Burman J, et al. Intestinal microbiome in hematopoietic stem cell transplantation for autoimmune diseases: considerations and perspectives on behalf of autoimmune diseases working party (ADWP) of the EBMT. Front Oncol. 2021;11:722436. doi:10.3389/fonc.2021.722436
   PubMed Web of Science ®Google Scholar
• Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med. 2018;33(2):256–276. doi:10.3904/kjim.2018.036
   PubMed Web of Science ®Google Scholar
• Puerta-Alcalde P, Garcia-Vidal C. Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation. J Fung. 2021;7(10):848. doi:10.3390/jof7100848
   Web of Science ®Google Scholar
• Mellouli A, Chebbi Y, El Fatmi R, et al. Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients. Tunis Med. 2021;99(2):269–276. English. PMID: 33899198.
   PubMedGoogle Scholar
• Styczyński J, Tridello G, Koster L, et al. Infectious diseases working party EBMT. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):126–136. doi:10.1038/s41409-019-0624-z.
   PubMed Web of Science ®Google Scholar
• Kong SG, Jeong S, Lee S, et al. Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia. BMC Cancer. 2021;21(1):177. doi:10.1186/s12885-021-07897-3.
   PubMed Web of Science ®Google Scholar
• Gill J, Busca A, Cinatti N, et al. Bacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation: etiology, Risk factors and outcome in a single-center study. Microorganisms. 2023;11(3):742. doi:10.3390/microorganisms11030742
   PubMed Web of Science ®Google Scholar
• Herrera F, Torres D, Carena A, et al. Short course of antibiotic therapy for gram-negative bacilli bacteremia in patients with cancer and hematopoietic stem cell transplantation: less is possible. Microorganisms. 2023;11(2):511. doi:10.3390/microorganisms11020511
   PubMed Web of Science ®Google Scholar
• Goloshchapov OV, Shvetsov AN, Chukhlovin AB, et al. Incidence of common herpesviruses in colonic mucosal biopsies following hematopoietic stem cell transplantation. Microorganisms. 2022;10(11):2128. doi:10.3390/microorganisms10112128
   PubMed Web of Science ®Google Scholar
• Kamel NA, Alshahrani MY, Aboshanab KM, El Borhamy MI. Evaluation of the biofire filmarray pneumonia panel plus to the conventional diagnostic methods in determining the microbiological etiology of hospital-acquired pneumonia. Biology. 2022;11(3):377. doi:10.3390/biology11030377
   PubMedGoogle Scholar
• El Sherif HM, Elsayed M, El-Ansary MR, Aboshanab KM, El Borhamy MI, Elsayed KM. BioFire filmArray BCID2 versus VITEK-2 System in determining microbial etiology and antibiotic-resistant genes of pathogens recovered from central line-associated bloodstream infections. Biology. 2022;11(11):1573. doi:10.3390/biology11111573
   PubMedGoogle Scholar